IGF1 and breast cancer: These data support a role for CCN6 a modulator of the growth effects of IGF-1 on the breast epithelium, and may have clinical implications, as CCN6 loss may mark an epithelium at increased risk of malignant transformation and might constitute a target for breast cancer prevention.